Company Filing History:
Years Active: 2023
Title: Zhiwei Cao: Innovator in Pharmaceutical Sciences
Introduction
Zhiwei Cao is an accomplished inventor based in Basking Ridge, NJ, known for his contributions to pharmaceutical sciences. He has developed innovative solutions that address important medical challenges, particularly in the field of multi-tyrosine kinase inhibitors.
Latest Patents
Cao holds a patent for a crystalline salt of a multi-tyrosine kinase inhibitor. The invention pertains specifically to the malate salt of a multi-tyrosine kinase inhibitor with the chemical structure N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate (1:1). This patent includes pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form, and methods of use thereof, marking a significant advancement in therapeutic applications.
Career Highlights
Zhiwei Cao is currently employed at Mirati Therapeutics, Inc., where he continues to apply his expertise in drug development and formulation. His innovative work has been instrumental in progressing new treatment options for patients with various health conditions.
Collaborations
Throughout his career, Cao has collaborated with notable colleagues, including Patricia Andres and Ekaterina Albert. These collaborations have fostered a conducive environment for innovation and the sharing of expertise in pharmaceutical research.
Conclusion
Zhiwei Cao's contributions to the field of pharmaceutical sciences exemplify the transformative impact of innovation in healthcare. With his patent for a multi-tyrosine kinase inhibitor, he has played a crucial role in advancing therapeutic possibilities, showcasing the importance of collaboration and ingenuity in driving medical progress.